Search
Search Results
-
Advanced glycation end products and allergy
This review aims to summarize our current knowledge of the impact of advanced glycation products (AGEs) in the diet on the development of allergies....
-
Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study
BackgroundSeveral studies have highlighted the possible positive effects of soluble receptor for advanced glycation end products (sRAGE) against...
-
Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
BackgroundIn diabetic metabolic disorders, advanced glycation end products (AGEs) contribute significantly to the development of cardiovascular...
-
Effect of Advanced Glycation end Products (AGEs) on Sperm Parameters and Function in C57Bl/6 Mice
This study investigated the deleterious impact of advanced glycation end products (AGEs), commonly present in metabolic disorders like diabetes,...
-
Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome
BackgroundAdvanced glycation end products (AGEs) are known to associate with the pathogenesis of several chronic diseases via interaction with their...
-
Effectiveness of date seed on glycemia and advanced glycation end-products in type 2 diabetes: a randomized placebo-controlled trial
BackgroundType 2 diabetes mellitus (T2DM) is a chronic medical condition affecting more than 95% of people with diabetes. Traditionally, some...
-
Advanced Glycation End-Products of Follicular Fluid are Associated with Embryo Morphokinetic Parameters and ART Outcomes
Advanced glycation end products (AGEs) can disrupt antioxidant system and steroidogenesis, resulting in detrimental effects on assisted reproductive...
-
Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
BackgroundThe accumulation of advanced glycation end products (AGEs) is associated with cardiovascular events in patients with cardiovascular disease...
-
Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases
PurposeTo investigate for association between skin autofluorescence (SAF) advanced glycation end products (AGEs) and uveitis/scleritis activity in...
-
Correlation between circulating advanced glycation end products and thioredoxin-interacting protein levels and renal fat content in type 2 diabetes mellitus patients
BackgroundThis study sought to explore the clinical relevance of the associations of serum levels of advanced glycation end products (AGEs), soluble...
-
Catalpol Prevents Glomerular Angiogenesis Induced by Advanced Glycation End Products via Inhibiting Galectin-3
ObjectiveThe main characteristics of diabetic nephropathy (DN) at the early stage are abnormal angiogenesis of glomerular endothelial cells (GECs)...
-
Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study
PurposeThis study is aimed at evaluating the relationship between dietary and serum advanced glycation end-products (AGEs) with serum inflammatory...
-
Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
BackgroundTo evaluate the association of serum advanced glycation end-products (AGEs) and its soluble receptor of AGE (sRAGE) levels with...
-
Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
BackgroundAdvanced glycation end products (AGEs) have been linked to cardiovascular disease (CVD), especially coronary heart disease (CHD), but their...
-
Fingertip advanced glycation end products and psychotic symptoms among adolescents
Case control studies have suggested that advanced glycation end products play a key role in the pathophysiology of chronic schizophrenia. However,...
-
Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults
BackgroundDietary advanced glycation end products(AGEs) may contribute to increased inflammation and oxidative stress as risk factors for chronic...
-
Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
BackgroundThe soluble receptor for advanced glycation end products (sRAGE) has been proposed to serve as a marker for disease severity, but its role...
-
Association of major dietary patterns with advanced glycation end products and high-sensitivity C-reactive protein in people with type 1 diabetes mellitus
BackgroundThe associations of diet with serum levels of advanced glycation end products (AGEs) and high-sensitivity C-reactive protein (hs-CRP) have...
-
Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
Esophageal cancer is a malignant type of cancer with a high mortality rate. The aim of this study is to determine co-expression patterns of...
-
Advanced glycation end products and diabetes and other metabolic indicators
BackgroundDiabetes is a global concern among adults. Previous studies have suggested an association between different screening methods and diabetes;...
